PBI41 LONGITUDINAL EVALUATION OF PRODUCT UTILIZATION AND CHARACTERISTICS AMONG PATIENTS TREATED WITH BIOLOGIC ANTI-INFLAMMATORY AGENTS: A STUDY BY THE BIOLOGICS AND BIOSIMILARS COLLECTIVE INTELLIGENCE CONSORTIUM
May 1, 2020, 00:00
10.1016/j.jval.2020.04.104
https://www.valueinhealthjournal.com/article/S1098-3015(20)30292-8/fulltext
Title :
PBI41 LONGITUDINAL EVALUATION OF PRODUCT UTILIZATION AND CHARACTERISTICS AMONG PATIENTS TREATED WITH BIOLOGIC ANTI-INFLAMMATORY AGENTS: A STUDY BY THE BIOLOGICS AND BIOSIMILARS COLLECTIVE INTELLIGENCE CONSORTIUM
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30292-8&doi=10.1016/j.jval.2020.04.104
First page :
Section Title :
Open access? :
No
Section Order :
10562